Earnings Call · Q4 FY2022·2023-02-28

Q4 22EPS +14.00%·Rev n/aQ3 22EPS +5.88%·Rev n/aQ2 22EPS +14.29%·Rev n/aQ1 22EPS +24.14%·Rev n/a⚠ consensus missing

Altimmune, Inc. ALT

Richard Eisenstadt — Chief Financial Officer

Vipin Garg — Chief Executive Officer

Scott Harris — Chief Medical Officer

+6.4%1d on move date+6.8% vs SPY3d−2.3%5d−1.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ALT calls or request research access.

More ALT calls Browse calls Request research access